Recombinant Saccharomyces cerevisiae Solute carrier family 25 member 38 homolog (SCRG_00613)

What is the recommended expression system for SCRG_00613?

Based on successful approaches with other solute carrier family 25 members, Escherichia coli expression systems, particularly E. coli Rosetta-gami B(DE3) cells, are recommended for high-level expression of SCRG_00613. This bacterial expression system has demonstrated effective production of similar proteins as inclusion bodies that can be subsequently purified by centrifugation and washing . The expression vector should contain the coding sequence for SCRG_00613 under the control of an inducible promoter, which allows for controlled protein production after bacterial growth reaches optimal density. Post-purification, protein identity should be confirmed via MALDI-TOF mass spectrometry to ensure the integrity of the recombinant protein.

How should researchers design experiments to determine the substrate specificity of SCRG_00613?

The experimental design for determining substrate specificity should follow a systematic approach:

• Reconstitute purified SCRG_00613 into liposomes following standard protocols used for mitochondrial carriers

• Prepare a diverse panel of potential substrates, including various amino acids, carnitine, acylcarnitines, and other metabolites

• Conduct homoexchange experiments with the same substrate inside and outside the liposomes

• Use radiolabeled substrates (e.g., [³H] or [¹⁴C]-labeled compounds) to track transport activity

• Include inhibition controls using established inhibitors of mitochondrial carriers (e.g., pyridoxal 5′-phosphate and HgCl₂)

• Implement appropriate negative controls including:

  • Boiled protein before incorporation into liposomes

  • Liposomes reconstituted with material from bacterial cells lacking the SCRG_00613 coding sequence

  • Liposomes reconstituted with unrelated mitochondrial carriers

  • Pure liposomes without incorporated protein

What methodological approach should be used to confirm the mitochondrial localization of SCRG_00613?

Confirming mitochondrial localization requires a multi-method approach:

• Subcellular fractionation: Isolate mitochondria from yeast cells expressing SCRG_00613 using differential centrifugation, followed by Western blot analysis using antibodies against SCRG_00613 and established mitochondrial marker proteins.

• Fluorescence microscopy: Generate a SCRG_00613-GFP fusion protein and co-stain with mitochondria-specific dyes (e.g., MitoTracker) to visualize localization in live cells.

• Immunogold electron microscopy: Use antibodies against SCRG_00613 coupled with gold particles to precisely localize the protein within mitochondrial subcompartments.

• Protease protection assays: Treat isolated mitochondria with proteases in the presence or absence of detergents to determine the orientation and membrane topology of SCRG_00613.

This comprehensive approach provides multiple lines of evidence for mitochondrial localization and helps determine the exact submitochondrial compartment where SCRG_00613 functions .

How can researchers differentiate between uniport and exchange mechanisms for SCRG_00613 transport activity?

Distinguishing between uniport (one-way transport) and exchange (counter-exchange transport) mechanisms requires specialized transport assays:

• For exchange activity measurement:

  • Preload liposomes with high concentrations of potential substrates (10 mM)

  • Add radiolabeled substrate at lower concentration externally (0.4 mM)

  • Monitor the uptake of radiolabeled substrate over time

  • A positive result indicates exchange of internal for external substrate

• For uniport activity measurement:

  • Prepare liposomes without internal substrate

  • Add radiolabeled substrate externally

  • Monitor uptake over time

  • Compare rates with exchange experiments

• Efflux experiments:

  • Preload liposomes containing SCRG_00613 with radiolabeled substrate

  • Dilute into buffer without substrate

  • Monitor efflux of radiolabeled substrate

  • Uniporters will show significant efflux, while strict exchangers will not

• Analysis of transport kinetics:

  • Calculate the ratio of exchange rate to uniport rate

  • Similar to SLC25A29, if SCRG_00613 operates both mechanisms, exchange rates are typically 2.8-10 fold higher than uniport rates

These methodological approaches allow researchers to definitively characterize the transport mechanism of SCRG_00613 and its physiological relevance.

What experimental approaches can resolve contradictory data regarding substrate specificity of SCRG_00613?

When faced with contradictory results regarding substrate specificity, implement this systematic troubleshooting approach:

• Standardize protein preparation:

  • Ensure consistent purification methods across experiments

  • Verify protein integrity through circular dichroism and thermal stability assays

  • Quantify protein incorporation into liposomes

• Modify experimental conditions:

  • Test transport at different pH values (6.5-8.0)

  • Vary membrane composition of liposomes

  • Test different internal:external substrate concentration ratios

• Cross-validation with multiple techniques:

  • Complement liposome-based assays with whole-cell transport studies in yeast

  • Perform competition assays between substrates

  • Use isothermal titration calorimetry to directly measure substrate binding

• Genetic approaches:

  • Create point mutations in conserved residues predicted to be involved in substrate binding

  • Analyze transport properties of chimeric proteins containing domains from related carriers

  • Perform complementation studies in yeast strains lacking related transporters

• Data analysis framework:

This comprehensive approach addresses discrepancies by identifying experimental variables that may lead to contradictory results .

How should researchers design experiments to determine the physiological role of SCRG_00613 in S. cerevisiae metabolism?

Determining the physiological role requires a multi-faceted approach combining genetic, biochemical, and metabolomic methods:

• Generate and characterize knockout strains:

  • Create precise gene deletions using CRISPR-Cas9 or homologous recombination

  • Analyze growth phenotypes under various nutrient conditions and stresses

  • Perform complementation studies with wild-type and mutant versions

• Metabolomic profiling:

  • Compare metabolite levels between wild-type and knockout strains using LC-MS/MS

  • Focus on pathways involving predicted substrates

  • Perform flux analysis with isotope-labeled substrates

• Genetic interaction screening:

  • Conduct synthetic genetic array (SGA) analysis to identify genetic interactions

  • Perform suppressor screens to identify compensatory pathways

  • Create double mutants with genes encoding related transporters

• Physiological assays:

  • Measure oxygen consumption rates and mitochondrial membrane potential

  • Assess mitochondrial protein synthesis rates

  • Analyze amino acid pools in mitochondrial and cytosolic compartments

• Integrated data analysis framework:

This systematic approach provides multiple lines of evidence for the physiological role of SCRG_00613, enabling researchers to distinguish between direct functions and secondary effects .

What are the critical factors in purifying SCRG_00613 for functional studies?

Successful purification of functional SCRG_00613 requires attention to these critical factors:

• Expression optimization:

  • Determine optimal induction conditions (temperature, inducer concentration, time)

  • Test multiple E. coli strains (BL21, Rosetta, C41/C43 for membrane proteins)

  • Consider codon optimization of the sequence for E. coli expression

• Inclusion body processing:

  • Implement thorough washing steps to remove contaminants

  • Use mild solubilization conditions to maintain secondary structure

  • Include protease inhibitors throughout purification process

• Protein refolding strategy:

  • Test different detergents for solubilization (Triton X-100, sarkosyl, LDAO)

  • Implement gradual dialysis to remove denaturants

  • Include stabilizing additives (glycerol, specific lipids)

• Quality control measures:

  • Assess homogeneity by size-exclusion chromatography

  • Verify identity by mass spectrometry

  • Confirm secondary structure by circular dichroism

  • Evaluate thermal stability using differential scanning fluorimetry

• Reconstitution optimization:

  • Test different protein-to-lipid ratios (typically 1:50 to 1:100)

  • Compare various lipid compositions to mimic mitochondrial inner membrane

  • Optimize reconstitution methods (freeze-thaw cycles, extrusion, sonication)

Applying these methodological considerations can yield approximately 40 mg of purified protein per liter of bacterial culture, sufficient for comprehensive functional characterization .

How can researchers determine the transport kinetics and substrate affinity of SCRG_00613?

Determining transport kinetics requires systematic analysis:

• Initial rate measurements:

  • Measure transport activity at very early time points (5-30 seconds)

  • Ensure linearity of transport with respect to time

  • Use substrate concentrations spanning at least two orders of magnitude (0.01-1 mM)

• Kinetic parameter determination:

  • Plot initial rates versus substrate concentration

  • Fit data to appropriate kinetic models (Michaelis-Menten, Hill equation)

  • Calculate Km, Vmax, and Hill coefficient values

• Inhibition studies:

  • Test competitive inhibitors at multiple concentrations

  • Calculate Ki values using appropriate equations

  • Determine inhibition mechanisms (competitive, non-competitive, uncompetitive)

• Temperature and pH dependence:

  • Measure transport rates at different temperatures (15-40°C)

  • Calculate activation energy using Arrhenius plots

  • Determine optimal pH and pH-dependent changes in substrate affinity

• Sample kinetic data analysis for mitochondrial carriers:

This comprehensive kinetic analysis provides critical insights into the transport mechanism and physiological role of SCRG_00613, enabling comparison with cytosolic concentrations of potential substrates to assess physiological relevance .

What approaches should be used to study the structure-function relationship of SCRG_00613?

Investigating structure-function relationships requires an integrated approach:

• Homology modeling and computational analysis:

  • Construct homology models based on crystallized mitochondrial carriers

  • Identify conserved motifs and potential substrate binding sites

  • Predict transmembrane domains and functional residues

  • Simulate substrate docking and transport pathway

• Site-directed mutagenesis strategy:

  • Target conserved residues in predicted substrate binding sites

  • Create conservative and non-conservative mutations

  • Focus on charged residues likely involved in substrate recognition

  • Introduce mutations in transmembrane domains and matrix/cytosolic loops

• Functional characterization of mutants:

  • Express and purify mutant proteins using identical conditions

  • Reconstitute into liposomes for transport assays

  • Compare kinetic parameters with wild-type protein

  • Analyze changes in substrate specificity and inhibitor sensitivity

• Advanced structural methods:

  • Attempt crystallization trials with various detergents and conditions

  • Consider lipidic cubic phase crystallization for membrane proteins

  • Explore cryo-EM for structure determination

  • Use cross-linking mass spectrometry to identify interaction domains

• Structure-function correlation framework:

This systematic approach links structural features to specific functional properties, providing insight into the molecular mechanism of substrate recognition and translocation by SCRG_00613 .

What statistical approaches are most appropriate for analyzing transport data for SCRG_00613?

When analyzing transport data for SCRG_00613, researchers should implement rigorous statistical methodology:

• Experimental design considerations:

  • Perform at least three independent protein preparations

  • Conduct each transport assay in triplicate or quadruplicate

  • Include appropriate positive and negative controls in each experiment

• Descriptive statistics:

  • Report mean values with standard deviation or standard error

  • Test for normality using Shapiro-Wilk or Kolmogorov-Smirnov tests

  • Consider data transformations if normality assumptions are violated

• Inferential statistics:

  • Use paired t-tests for comparing transport rates under different conditions

  • Implement ANOVA with post-hoc tests for comparing multiple conditions

  • Apply non-parametric alternatives (Mann-Whitney U, Kruskal-Wallis) when appropriate

• Regression analysis for kinetic data:

  • Use non-linear regression for fitting to Michaelis-Menten equation

  • Calculate confidence intervals for Km and Vmax values

  • Consider using global fitting for complex kinetic models

• Statistical analysis framework:

How should researchers interpret discrepancies between in vitro transport assays and in vivo phenotypes?

Resolving discrepancies between in vitro and in vivo results requires systematic investigation:

• Critical evaluation of in vitro system:

  • Assess whether reconstitution conditions accurately mimic the native membrane environment

  • Consider the impact of missing regulatory factors or interacting proteins

  • Evaluate potential artifacts from protein purification and reconstitution

• Comprehensive in vivo analysis:

  • Examine phenotypes under various growth conditions and stresses

  • Implement complementation with wild-type and mutant versions

  • Consider redundancy with other transporters that may mask phenotypes

  • Analyze subcellular metabolite distributions

• Bridging methodologies:

  • Implement transport assays in semi-intact cells or isolated mitochondria

  • Use inducible expression systems to correlate protein levels with function

  • Employ metabolic flux analysis with stable isotope labeling

• Integrated data interpretation framework:

This methodical approach helps researchers reconcile seemingly contradictory results between simplified in vitro systems and complex in vivo environments, leading to a more complete understanding of SCRG_00613 function .

What are the most promising approaches for studying the regulation of SCRG_00613 activity?

Investigating regulatory mechanisms requires multiple complementary approaches:

• Post-translational modification analysis:

  • Perform mass spectrometry to identify phosphorylation, acetylation, or ubiquitination

  • Create phosphomimetic and phosphodeficient mutants

  • Test activity under different metabolic conditions that may trigger modifications

• Transcriptional regulation:

  • Analyze promoter elements using reporter constructs

  • Identify transcription factors using chromatin immunoprecipitation

  • Study expression changes under different metabolic conditions and stresses

• Protein-protein interactions:

  • Conduct pull-down assays and co-immunoprecipitation experiments

  • Perform membrane yeast two-hybrid screening

  • Use proximity labeling approaches (BioID, APEX) in mitochondria

• Metabolic regulation:

  • Test allosteric regulation by metabolites not transported by SCRG_00613

  • Analyze transport activity in response to changes in membrane potential

  • Investigate effects of lipid environment on transport function

• Integrated regulatory network analysis:

This comprehensive investigation of regulatory mechanisms provides insight into how SCRG_00613 activity is integrated into the broader metabolic network of S. cerevisiae .